Close
Division of Medicine Case and Seminar: Professor Martin Cannon UAMS
02 July 2024, 1:00 pm–2:00 pm
‘Immune regulation, clinical outcomes and Th17-DC vaccination for ovarian cancer.’
This event is free.
Event Information
Open to
- UCL staff | UCL students
Availability
- Yes
Cost
- Free
Organiser
-
Alison Kelly – Division of Medicine
'Immune regulation, clinical outcomes and Th17-DC vaccination for ovarian cancer.'
Professor Martin Cannon
Department of Microbiology and Immunology
University of Arkansas for Medical Sciences (UAMS)
Host: Professor Richard Stratton
Department for Inflammation, Division of Medicine
Tuesday 2nd July 2024 at 13:00
This seminar will be presented in Second Floor Seminar Room of the Rayne Buiding and will be broadcast live to the Royal Free Hospital
The development of DC vaccination strategies to boost Th17 immunity in ovarian cancer patients represents a significant step forward, but there remains the question of whether DC vaccination alone would be sufficient to provide clinical benefit in the face of continuing local immune suppression in the tumor microenvironment. In partnership with investigators at MD Anderson Cancer Center, the Mayo Clinic and the University of Pennsylvania, our laboratory is focused on strategies that alleviate myeloid cell-mediated immune suppression and boost the efficacy of DC vaccination and other immunotherapies for ovarian cancer.
The seminars are open to UCL & UCLH staff, students and their visitors. Please contact alison.kelly@ucl.ac.uk for all enquires
Audience members: Please ensure that your mic is muted and video is turned off during the talk. There will be a 10-minute Q&A at the end of the talk. Please ensure that you use the ‘raise hand’ function if you would like to ask a question. Thank you.